PubMed=6778921; DOI=10.4049/jimmunol.126.2.596
Smith R.G., Dev V.G., Shannon W.A. Jr.
Characterization of a novel human pre-B leukemia cell line.
J. Immunol. 126:596-602(1981)

PubMed=8547074; DOI=10.1111/j.1365-2141.1995.tb05302.x
Siebert R., Willers C.P., Schramm A., Fossa A., Dresen I.M.G., Uppenkamp M.J., Nowrousian M.R., Seeber S., Opalka B.
Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.
Br. J. Haematol. 91:350-354(1995)

PubMed=9067587; DOI=10.1038/sj.leu.2400571
Uphoff C.C., MacLeod R.A.F., Denkmann S.A., Golub T.R., Borkhardt A., Janssen J.W.G., Drexler H.G.
Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
Leukemia 11:441-447(1997)

PubMed=9207458; DOI=10.1182/blood.V90.1.234
White L.J., Ozanne B.W., Graber P., Aubry J.-P., Bonnefoy J.-Y., Cushley W.
Inhibition of apoptosis in a human pre-B-cell line by CD23 is mediated via a novel receptor.
Blood 90:234-243(1997)

PubMed=11986953; DOI=10.1038/sj.leu.2402485
O'Donnell P.H., Guo W.-X., Reynolds C.P., Maurer B.J.
N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.
Leukemia 16:902-910(2002)